you are here: HomeNewsBusiness

Coronavirus pandemic | Wipro, Azim Premji Foundation commit Rs 1,125cr

Out of this, Rs 1,000 crore will come from Azim Premji Foundation and the rest from Wipro and Wipro Enterprises.

April 01, 2020 / 03:27 PM IST
Business tycoon Azim Premji

Business tycoon Azim Premji

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Software major Wipro, Wipro Enterprises and Azim Premji Foundation have together committed Rs 1,125 crore towards the coronavirus outbreak.

"These resources will help enable the dedicated medical and service fraternity in the frontline of the battle against the pandemic and in mitigating its wide-ranging human impact, particularly on the most disadvantaged of our society," as per a company statement.

Of the Rs 1,125 crore, Wipro's commitment is Rs 100 crore, Wipro Enterprises Ltd's is Rs 25 crore, and that of the Azim Premji Foundation is Rs 1,000 crore, it added.

The amount is in addition to the annual corporate social responsibility (CSR) activities, and above the usual expenditure of Azim Premji Foundation, the statement said.

Several large corporations have been donating money through various ways towards tackling the COVID-19 outbreak. Many companies have contributed to the PM Citizen Assistance and Relief in Emergency Situations (PM CARES) Fund.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
(With inputs from PTI)
Moneycontrol News
first published: Apr 1, 2020 01:28 pm

stay updated

Get Daily News on your Browser
Sections